82
Participants
Start Date
November 22, 2001
Primary Completion Date
August 3, 2004
Study Completion Date
August 3, 2004
Antihemophilic factor, recombinant, manufactured protein-free
Allgemeines Krankenhaus der Stadt Wien, Vienna
KU Leuven Universitaire Ziekenhuizen, Leuven
Cornell Medical Center, New York
Mt. Sinai Medical School, New York
Ospedale Maggiore di Milano, Milan
Childrens Healthcare of Atlanta Blood Bank, Atlanta
Medizinische Hochschule Hannover, Hanover
Children's Hospital Medical Center Pharmacy, Cincinnati
Indiana Hemophilia & Thrombosis Center, Indianapolis
Michigan State University, East Lansing
Klinikum der J. W. Goethe - Universität, Frankfurt am Main
Comprehensive Bleeding Disorders Center, Peoria
Hôpital Edouard Herriot, Lyon
Mountain States Regional Hemophilia and Thrombosis Center, Aurora
University of Medicine & Dentistry of New Jersey, New Brunswick
Hemophilia Center of Western Pennsylvania, Pittsburgh
Puget Sound Blood Center, Seattle
University of Alberta, Calgary
Klinikum Innenstadt der Universität München, Munich
University Hospital MAS, Malmo
The Royal Free Hospital, London
Central Manchester Healthcare NHS Trust, Manchester
The Churchill Hospital, Oxford
University Hospital of Wales, Cardiff
Baxalta now part of Shire
INDUSTRY